126 related articles for article (PubMed ID: 24055891)
1. Different susceptibility of colon cancer DLD-1 and LOVO cell lines to apoptosis induced by DMU-212, a synthetic resveratrol analogue.
Piotrowska H; Myszkowski K; Amarowicz R; Murias M; Kulcenty K; Wierzchowski M; Jodynis-Liebert J
Toxicol In Vitro; 2013 Dec; 27(8):2127-34. PubMed ID: 24055891
[TBL] [Abstract][Full Text] [Related]
2. The Effect of 4'-hydroxy-3,4,5-trimetoxystilbene, the Metabolite of Resveratrol Analogue DMU-212, on Growth, Cell Cycle and Apoptosis in DLD-1 and LOVO Colon Cancer Cell Lines.
Jozkowiak M; Skupin-Mrugalska P; Nowicki A; Borys-Wojcik S; Wierzchowski M; Kaczmarek M; Ramlau P; Jodynis-Liebert J; Piotrowska-Kempisty H
Nutrients; 2020 May; 12(5):. PubMed ID: 32392733
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol analogue 3,4,4',5-tetramethoxystilbene inhibits growth, arrests cell cycle and induces apoptosis in ovarian SKOV-3 and A-2780 cancer cells.
Piotrowska H; Myszkowski K; Ziółkowska A; Kulcenty K; Wierzchowski M; Kaczmarek M; Murias M; Kwiatkowska-Borowczyk E; Jodynis-Liebert J
Toxicol Appl Pharmacol; 2012 Aug; 263(1):53-60. PubMed ID: 22687606
[TBL] [Abstract][Full Text] [Related]
4. Role of CYP1A1 in the biological activity of methylated resveratrol analogue, 3,4,5,4'-tetramethoxystilbene (DMU-212) in ovarian cancer A-2780 and non-cancerous HOSE cells.
Piotrowska-Kempisty H; Klupczyńska A; Trzybulska D; Kulcenty K; Sulej-Suchomska AM; Kucińska M; Mikstacka R; Wierzchowski M; Murias M; Baer-Dubowska W; Kokot Z; Jodynis-Liebert J
Toxicol Lett; 2017 Feb; 267():59-66. PubMed ID: 28049037
[TBL] [Abstract][Full Text] [Related]
5. 3'-hydroxy-3,4,5,4'-tetramethoxystilbene, the metabolite of resveratrol analogue DMU-212, inhibits ovarian cancer cell growth in vitro and in a mice xenograft model.
Piotrowska-Kempisty H; Ruciński M; Borys S; Kucińska M; Kaczmarek M; Zawierucha P; Wierzchowski M; Łażewski D; Murias M; Jodynis-Liebert J
Sci Rep; 2016 Sep; 6():32627. PubMed ID: 27585955
[TBL] [Abstract][Full Text] [Related]
6. Expression of CYP1A1, CYP1B1 and MnSOD in a panel of human cancer cell lines.
Piotrowska H; Kucinska M; Murias M
Mol Cell Biochem; 2013 Nov; 383(1-2):95-102. PubMed ID: 23873331
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) mediates anti-tumor effects via mechanism different from that of resveratrol.
Ma Z; Molavi O; Haddadi A; Lai R; Gossage RA; Lavasanifar A
Cancer Chemother Pharmacol; 2008 Dec; 63(1):27-35. PubMed ID: 18286288
[TBL] [Abstract][Full Text] [Related]
8. DMU-212 inhibits tumor growth in xenograft model of human ovarian cancer.
Piotrowska H; Myszkowski K; Abraszek J; Kwiatkowska-Borowczyk E; Amarowicz R; Murias M; Wierzchowski M; Jodynis-Liebert J
Biomed Pharmacother; 2014 May; 68(4):397-400. PubMed ID: 24768110
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol inhibits TCDD-induced expression of CYP1A1 and CYP1B1 and catechol estrogen-mediated oxidative DNA damage in cultured human mammary epithelial cells.
Chen ZH; Hurh YJ; Na HK; Kim JH; Chun YJ; Kim DH; Kang KS; Cho MH; Surh YJ
Carcinogenesis; 2004 Oct; 25(10):2005-13. PubMed ID: 15142886
[TBL] [Abstract][Full Text] [Related]
10. Effect of resveratrol analogue, DMU-212, on antioxidant status and apoptosis-related genes in rat model of hepatocarcinogenesis.
Piotrowska H; Kujawska M; Nowicki M; Petzke E; Ignatowicz E; Krajka-Kuźniak V; Zawierucha P; Wierzchowski M; Murias M; Jodynis-Liebert J
Hum Exp Toxicol; 2017 Feb; 36(2):160-175. PubMed ID: 27048571
[TBL] [Abstract][Full Text] [Related]
11. CYP1A1 and CYP1B1 expressions in medulloblastoma cells are AhR-independent and have no direct link with resveratrol-induced differentiation and apoptosis.
Wu ML; Li H; Wu DC; Wang XW; Chen XY; Kong QY; Ma JX; Gao Y; Liu J
Neurosci Lett; 2005 Aug 12-19; 384(1-2):33-7. PubMed ID: 15893423
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling of DMU-212-induced apoptosis and anti-angiogenesis in vascular endothelial cells.
Miao Y; Cui L; Chen Z; Zhang L
Pharm Biol; 2016; 54(4):660-6. PubMed ID: 26428916
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4'-tetramethoxystilbene.
Sale S; Verschoyle RD; Boocock D; Jones DJ; Wilsher N; Ruparelia KC; Potter GA; Farmer PB; Steward WP; Gescher AJ
Br J Cancer; 2004 Feb; 90(3):736-44. PubMed ID: 14760392
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of CYP1A1 and CYP1B1 expression in resveratrol-treated human medulloblastoma cells.
Liu J; Wang Q; Wu DC; Wang XW; Sun Y; Chen XY; Zhang KL; Li H
Neurosci Lett; 2004 Jun; 363(3):257-61. PubMed ID: 15182955
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor properties of methoxylated analogues of resveratrol in malignant MCF-7 but not in non-tumorigenic MCF-10A mammary epithelial cell lines.
van den Brand AD; Villevoye J; Nijmeijer SM; van den Berg M; van Duursen MBM
Toxicology; 2019 Jun; 422():35-43. PubMed ID: 31004704
[TBL] [Abstract][Full Text] [Related]
16. The Effect of 3'-Hydroxy-3,4,5,4'-Tetramethoxy -stilbene, the Metabolite of the Resveratrol Analogue DMU-212, on the Motility and Proliferation of Ovarian Cancer Cells.
Nowicki A; Skupin-Mrugalska P; Jozkowiak M; Wierzchowski M; Rucinski M; Ramlau P; Krajka-Kuzniak V; Jodynis-Liebert J; Piotrowska-Kempisty H
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046103
[TBL] [Abstract][Full Text] [Related]
17. Anticancer effects of the metabolic products of the resveratrol analogue, DMU-212: structural requirements for potency.
Androutsopoulos VP; Ruparelia KC; Papakyriakou A; Filippakis H; Tsatsakis AM; Spandidos DA
Eur J Med Chem; 2011 Jun; 46(6):2586-95. PubMed ID: 21497957
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol engages selective apoptotic signals in gastric adenocarcinoma cells.
Riles WL; Erickson J; Nayyar S; Atten MJ; Attar BM; Holian O
World J Gastroenterol; 2006 Sep; 12(35):5628-34. PubMed ID: 17007014
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of the chemopreventive agent resveratrol and its synthetic analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) on adenoma development in the Apc(Min+) mouse and cyclooxygenase-2 in human-derived colon cancer cells.
Sale S; Tunstall RG; Ruparelia KC; Potter GA; Steward WP; Gescher AJ
Int J Cancer; 2005 Jun; 115(2):194-201. PubMed ID: 15688382
[TBL] [Abstract][Full Text] [Related]
20. Expression of CYP1A1 and CYP1B1 depends on cell-specific factors in human breast cancer cell lines: role of estrogen receptor status.
Angus WG; Larsen MC; Jefcoate CR
Carcinogenesis; 1999 Jun; 20(6):947-55. PubMed ID: 10357772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
